Publication | Closed Access

The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer

Breast OncologyCancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerTumor-host InterfaceImmunotherapyMedicineCell BiologyCd4/cd8 RatioTumor MicroenvironmentTumor Biology